Anemia Management and Association of Race With Mortality and Hospitalization in a Large Not-for-Profit Dialysis Organization
Authors:
- Klemens B. MeyerKMKlemens B. Meyer
- Philip G. ZagerPZPhilip G. Zager
- 1 September 2009
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 54 (3) , 498-510
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patientsNephrology Dialysis Transplantation, 2008
- Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in HemodialysisAmerican Journal of Kidney Diseases, 2008
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2008
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Revisiting Survival Differences by Race and Ethnicity among Hemodialysis PatientsJournal of the American Society of Nephrology, 2006
- Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRDAmerican Journal of Kidney Diseases, 2006
- Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney diseaseKidney International, 2005
- Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinKidney International, 2005
- Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimensKidney International, 2004
- Survival analysis for recurrent event data: an application to childhood infectious diseasesStatistics in Medicine, 2000